ORIGINAL RESEARCH
Published on 28 Mar 2025
Escitalopram oxalate-loaded chitosan nanoparticle in situ gel formulation intended for direct nose-to-brain delivery: in vitro, ex vivo, and in vivo pharmacokinetic evaluation
doi 10.3389/fphar.2025.1577331
- 115 views